Your browser is no longer supported. Please, upgrade your browser.
Aethlon Medical, Inc.
Index- P/E- EPS (ttm)-0.65 Insider Own1.00% Shs Outstand14.57M Perf Week46.81%
Market Cap82.52M Forward P/E10.72 EPS next Y0.52 Insider Trans0.00% Shs Float10.86M Perf Month2.22%
Income-7.90M PEG- EPS next Q-0.13 Inst Own15.60% Short Float2.64% Perf Quarter187.50%
Sales0.70M P/S117.89 EPS this Y65.10% Inst Trans143.39% Short Ratio0.05 Perf Half Y109.09%
Book/sh0.65 P/B8.49 EPS next Y165.40% ROA-57.50% Target Price- Perf Year164.11%
Cash/sh0.66 P/C8.34 EPS next 5Y- ROE-63.10% 52W Range1.22 - 12.49 Perf YTD123.48%
Dividend- P/FCF- EPS past 5Y41.90% ROI-83.90% 52W High-55.80% Beta0.66
Dividend %- Quick Ratio7.50 Sales past 5Y-5.80% Gross Margin- 52W Low352.83% ATR0.63
Employees10 Current Ratio7.50 Sales Q/Q51.10% Oper. Margin- RSI (14)59.83 Volatility24.68% 12.77%
OptionableYes Debt/Eq0.00 EPS Q/Q28.60% Profit Margin- Rel Volume0.22 Prev Close5.86
ShortableYes LT Debt/Eq0.00 EarningsJun 24 AMC Payout- Avg Volume5.94M Price5.52
Recom2.00 SMA2018.19% SMA5040.52% SMA200121.32% Volume1,287,020 Change-5.80%
Jul-01-21 10:09AM  
Jun-24-21 04:15PM  
Jun-21-21 03:27PM  
Jun-15-21 09:08PM  
Jun-11-21 11:29AM  
Jun-10-21 09:10AM  
Jun-09-21 02:27PM  
Jun-08-21 12:22PM  
Jun-03-21 08:01AM  
May-25-21 10:10AM  
Mar-01-21 08:02AM  
Feb-11-21 06:10AM  
Feb-10-21 02:30PM  
Feb-07-21 01:06AM  
Feb-04-21 08:02AM  
Jan-29-21 04:32AM  
Jan-06-21 08:02AM  
Jan-04-21 08:02AM  
Dec-16-20 08:02AM  
Nov-03-20 08:01AM  
Oct-29-20 11:45AM  
Oct-28-20 04:15PM  
Oct-19-20 08:01AM  
Oct-13-20 10:30AM  
Sep-09-20 08:01AM  
Aug-27-20 08:01AM  
Aug-11-20 04:15PM  
Aug-06-20 12:43AM  
Jun-25-20 04:15PM  
Jun-22-20 08:31AM  
Jun-18-20 12:49PM  
Jun-16-20 08:30AM  
Mar-24-20 08:58AM  
Mar-06-20 12:08PM  
Feb-25-20 03:25PM  
Feb-24-20 10:22AM  
Feb-17-20 01:37PM  
Feb-13-20 05:35AM  
Feb-10-20 04:15PM  
Feb-06-20 08:01AM  
Jan-23-20 01:02PM  
Jan-22-20 02:28PM  
Jan-21-20 02:40PM  
Jan-17-20 08:49AM  
Dec-17-19 04:18PM  
Dec-13-19 07:00AM  
Nov-15-19 05:04AM  
Nov-01-19 04:15PM  
Oct-29-19 03:17PM  
Oct-28-19 07:00AM  
Oct-14-19 03:55PM  
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shah ChetanDirectorDec 17Sale2.1126,85256,58016,641Dec 18 05:00 PM